Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results

Arrowhead Pharmaceuticals Inc. (ARWR) Reports Q2 EPS of $0.45

May 2, 2023 4:26 PM EDT

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of $0.45, versus $0.41 reported last year. Revenue for the quarter came in at $146.3 million, versus $151.8 million reported last year.

For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.

... More